Receptor tyrosine kinases
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
<StructureSection load='1dq8' size='490' side='right' caption='Solved Structures of Ephrin Type-A Receptors, [[1dq8]]' scene='Ephrin_Type-A_Receptor/Opening/1'> | <StructureSection load='1dq8' size='490' side='right' caption='Solved Structures of Ephrin Type-A Receptors, [[1dq8]]' scene='Ephrin_Type-A_Receptor/Opening/1'> | ||
| - | Receptor tyrosine kinases (RTKs) are part of the larger family of protein [[Tyrosine kinase|tyrosine kinases]]. They are the high-affinity cell surface receptors for many polypeptide growth factors, cytokines, and [[Hormone|hormones]]. Approximately 20 different RTK classes have been identified.<ref>PMID:26579483</ref> | + | Receptor tyrosine kinases (RTKs) are part of the larger family of protein [[Tyrosine kinase|tyrosine kinases]]. They are the high-affinity cell surface receptors for many polypeptide [[Growth factors|growth factors]], cytokines, and [[Hormone|hormones]]. Approximately 20 different RTK classes have been identified.<ref>PMID:26579483</ref> |
*RTK class I [[Epidermal Growth Factor Receptor]] family | *RTK class I [[Epidermal Growth Factor Receptor]] family | ||
*RTK class II [[Insulin receptor]] family | *RTK class II [[Insulin receptor]] family | ||
Revision as of 11:15, 11 December 2019
| |||||||||||
References
- ↑ Segaliny AI, Tellez-Gabriel M, Heymann MF, Heymann D. Receptor tyrosine kinases: Characterisation, mechanism of action and therapeutic interests for bone cancers. J Bone Oncol. 2015 Jan 23;4(1):1-12. doi: 10.1016/j.jbo.2015.01.001. eCollection , 2015 Mar. PMID:26579483 doi:http://dx.doi.org/10.1016/j.jbo.2015.01.001
